Abstract:Molecular recognition is fundamental in biology, underpinning intricate processes through specific protein–ligand interactions. This understanding is pivotal in drug discovery, yet traditional experimental methods face limitations in exploring the vast chemical space. Computational approaches, notably quantitative structure–activity/property relationship analysis, have gained prominence. Molecular fingerprints encode molecular structures and serve as property profiles, which are essential in drug discovery. While two-dimensional (2D) fingerprints are commonly used, three-dimensional (3D) structural interaction fingerprints offer enhanced structural features specific to target proteins. Machine learning models trained on interaction fingerprints enable precise binding prediction. Recent focus has shifted to structure-based predictive modeling, with machine-learning scoring functions excelling due to feature engineering guided by key interactions. Notably, 3D interaction fingerprints are gaining ground due to their robustness. Various structural interaction fingerprints have been developed and used in drug discovery, each with unique capabilities. This review recapitulates the developed structural interaction fingerprints and provides two case studies to illustrate the power of interaction fingerprint-driven machine learning. The first elucidates structure–activity relationships in β2 adrenoceptor ligands, demonstrating the ability to differentiate agonists and antagonists. The second employs a retrosynthesis-based pre-trained molecular representation to predict protein–ligand dissociation rates, offering insights into binding kinetics. Despite remarkable progress, challenges persist in interpreting complex machine learning models built on 3D fingerprints, emphasizing the need for strategies to make predictions interpretable. Binding site plasticity and induced fit effects pose additional complexities. Interaction fingerprints are promising but require continued research to harness their full potential.

Using Interaction Fingerprints as a Strategy of Protein-Ligand Interaction Patterns Recognition and Post-Docking Analysis

Fingerprinting Interactions between Proteins and Ligands for Facilitating Machine Learning in Drug Discovery

An Ensemble Learning-Based Method for Inferring Drug-Target Interactions Combining Protein Sequences and Drug Fingerprints

Drug interaction profiles classification: Sørensen–Dice coefficient based on MM/GBSA energies to explore focal adhesion kinase inhibitors

Comparison of Ligand-, Target Structure-, and Protein-Ligand Interaction Fingerprint-based Virtual Screening Methods

NEQUIM Contact System (NCS): A tool for generation and analysis of protein-ligand interaction fingerprint

A molecular representation to identify isofunctional molecules

Molecular docking as a popular tool in drug design, an in silico travel

Molecular Docking and Structure-Based Drug Design Strategies

An Integrated Approach to Ligand- and Structure-Based Drug Design: Development and Application to a Series of Serine Protease Inhibitors

On Evaluating Molecular-Docking Methods for Pose Prediction and Enrichment Factors

3D-Pharma, A Ligand-based Virtual Screening tool using 3D Pharmacophore Fingerprints

Docking Challenge: Protein Sampling and Molecular Docking Performance

Structural Protein–Ligand Interaction Fingerprints (SPLIF) for Structure-Based Virtual Screening: Method and Benchmark Study

Improving Protein-Ligand Docking Results with High-Throughput Molecular Dynamics Simulations

Pharmacophore Fingerprint-Based Approach to Binding Site Subpocket Similarity and Its Application to Bioisostere Replacement

Key Topics in Molecular Docking for Drug Design

Molecular Docking Using Chimera and Autodock Vina Software for Nonbioinformaticians

High-Throughput Docking Using Quantum Mechanical Scoring

Compact assessment of molecular surface complementarities enhances neural network-aided prediction of key binding residues

Insights into the Molecular Mechanisms of Protein-Ligand Interactions by Molecular Docking and Molecular Dynamics Simulation: A Case of Oligopeptide Binding Protein